Evidence mounts linking aspirin to lower risk of ovarian cancer

(H. Lee Moffitt Cancer Center& Research Institute) A new study found that women who reported taking a low-dose aspirin every day had a 23 percent lower risk of ovarian cancer compared to nonaspirin users. The research also found that women who were heavy users of nonaspirin nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen (Advil) or naproxen (Aleve), over a long period of time had a higher risk of developing ovarian cancer.

https://www.eurekalert.org/pub_releases/2018-10/hlmc-eml100418.php

Source: EurekAlert! - Cancer - October 4, 2018 Category: Cancer & Oncology Source Type: news